| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1159132L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0159132 |
| P932 | PMC publication ID | 4951129 |
| P698 | PubMed publication ID | 27434276 |
| P50 | author | Siu King Cheung | Q74141070 |
| Chung Yan Grace Lui | Q79320430 | ||
| Nelson L. Lee | Q47633764 | ||
| P2093 | author name string | Chun Kwok Wong | |
| Lin Zheng | |||
| Kin Wing Choi | |||
| Margaret Ip | |||
| Ka Tak Wong | |||
| Irene M H Yung | |||
| Yi Jun Chu | |||
| Winnie W Y Sin | |||
| Judy S Y Lam | |||
| P2860 | cites work | Tuberculosis | Q56067169 |
| Activation of the NLRP3 inflammasome byMycobacterium tuberculosisis uncoupled from susceptibility to active tuberculosis | Q57598527 | ||
| Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment | Q58857629 | ||
| Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare setting | Q59314230 | ||
| Soluble RAGE is deficient in neutrophilic asthma and COPD | Q60624707 | ||
| Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis* | Q60692857 | ||
| High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin | Q60692860 | ||
| Activation of PPARγ attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels | Q87211529 | ||
| Early clearance of Mycobacterium tuberculosis: a new frontier in prevention | Q38206209 | ||
| High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines | Q39042197 | ||
| Mycobacterial infection induces the secretion of high-mobility group box 1 protein | Q40004008 | ||
| High mobility group box 1 protein induction by Mycobacterium bovis BCG. | Q41952666 | ||
| Role of human Toll-like receptors in naturally occurring influenza A infections | Q44488921 | ||
| Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality | Q45192609 | ||
| Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection | Q45401003 | ||
| High-mobility group box 1 (HMGB1) as a master regulator of innate immunity | Q45863504 | ||
| Evaluation of high-mobility group box 1 protein concentration in serum of patients with M. tuberculosis infection. | Q46024883 | ||
| Receptor for advanced glycation end products is protective during murine tuberculosis | Q47621810 | ||
| Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease | Q47751181 | ||
| Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis | Q47772799 | ||
| Innate immune gene polymorphisms in tuberculosis | Q27000486 | ||
| High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 | ||
| HMGB1 and RAGE in inflammation and cancer | Q28274621 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Q29620722 | ||
| High mobility group box 1 in patients with 2009 pandemic H1N1 influenza-associated encephalopathy. | Q30352520 | ||
| Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. | Q30401263 | ||
| Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults | Q30408548 | ||
| CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis | Q33521270 | ||
| Soluble receptor for advanced glycation end-products and progression of airway disease | Q33613288 | ||
| A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis | Q33699642 | ||
| The immunology of tuberculosis: from bench to bedside | Q33777367 | ||
| A multifaceted analysis of immune-endocrine-metabolic alterations in patients with pulmonary tuberculosis | Q34056293 | ||
| Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis | Q34548732 | ||
| How can immunology contribute to the control of tuberculosis? | Q34572120 | ||
| Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. | Q34932689 | ||
| High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting | Q35124067 | ||
| The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis. | Q35705833 | ||
| Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis | Q35870599 | ||
| Establishment of Elevated Serum Levels of IL-10, IL-8 and TNF-β as Potential Peripheral Blood Biomarkers in Tubercular Lymphadenitis: A Prospective Observational Cohort Study | Q35897756 | ||
| Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response | Q35957846 | ||
| Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia | Q36190954 | ||
| Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis | Q36314493 | ||
| Host gene-encoded severe lung TB: from genes to the potential pathways | Q36457279 | ||
| Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis | Q36505201 | ||
| NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. | Q36839608 | ||
| Soluble forms of RAGE in human diseases: clinical and therapeutical implications | Q37411352 | ||
| HMGB1 in severe soft tissue infections caused by Streptococcus pyogenes | Q37531146 | ||
| An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. | Q38162032 | ||
| How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. | Q38205589 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| P304 | page(s) | e0159132 | |
| P577 | publication date | 2016-07-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis | |
| P478 | volume | 11 |
| Q64095043 | Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status |
| Q64266217 | HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses |
| Q55645471 | Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy. |
| Q60303389 | Inflammasomes: Pandora's box for sepsis |
| Q98158924 | Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment |
| Q89597501 | RNA Sensing of Mycobacterium tuberculosis and Its Impact on TB Vaccination Strategies |
| Q91819199 | Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy |
Search more.